Ruoyi Bio

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of recombinant protein drug intended for synthetic biology. Ruoyi Bio is based in Shanghai, China and was founded in 2018. Its last reported valuation was $23.4 million in Mar 2022. It has raised $7.6 million.

Last reported valuation
$23.4M
Oct 2026
Priced at
—
Total raised
$7.6M
Last round
—
How much has Ruoyi Bio raised?
$7.6Macross 0 recorded rounds
Free account
More of Ruoyi Bio with a free account
  • ·Watch Ruoyi Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ruoyi Bio investors

5 investors are on record for Ruoyi Bio, including YuanBio Venture Capital, Kunshan Industrial Technology Research Institute, Kunshan Guoke Venture Capital and Alan Asset Management.

For fundraisers
Raising for a company like Ruoyi Bio?

5 investors have backed Ruoyi Bio.

See all 5 investors →

Frequently asked about Ruoyi Bio

How much has Ruoyi Bio raised?
Ruoyi Bio has raised $7.6M in total across 0 recorded funding rounds.